Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Vandell AG"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vandell AG, Lobmeyer MT, Gawronski BE, Langaee TY, Gong Y, Gums JG, Beitelshees AL, Turner ST, Chapman AB, Cooper-DeHoff RM, Bailey KR, Boerwinkle E, Pepine CJ, Liggett SB, Johnson JA, Vandell, Alexander G, Lobmeyer, Maximilian T, Gawronski, Brian E, Langaee, Taimour Y, Gong, Yan
Publikováno v:
Hypertension (0194911X); Oct2012, Vol. 60 Issue 4, p957-964, 8p
Autor:
Limsakun T; Daiichi Sankyo, Inc, Basking Ridge, New Jersey, USA., Dishy V; Daiichi Sankyo, Inc, Basking Ridge, New Jersey, USA., Mendell J; Daiichi Sankyo, Inc, Basking Ridge, New Jersey, USA., Pizzagalli F; Daiichi Sankyo Development Ltd, Gerrards Cross, Buckinghamshire, UK., Pav J; Daiichi Sankyo, Inc, Basking Ridge, New Jersey, USA., Kochan J; Daiichi Sankyo, Inc, Basking Ridge, New Jersey, USA., Vandell AG; Daiichi Sankyo, Inc, Basking Ridge, New Jersey, USA., Rambaran C; Daiichi Sankyo, Inc, Basking Ridge, New Jersey, USA., Kobayashi F; Daiichi Sankyo Co, Ltd, Tokyo, Japan., Orihashi Y; Daiichi Sankyo Co, Ltd, Tokyo, Japan., Warren V; Daiichi Sankyo, Inc, Basking Ridge, New Jersey, USA., McPhillips P; Daiichi Sankyo Development Ltd, Gerrards Cross, Buckinghamshire, UK., Zhou J; Daiichi Sankyo, Inc, Basking Ridge, New Jersey, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2020 Jun; Vol. 60 (6), pp. 691-701. Date of Electronic Publication: 2020 Feb 27.
Autor:
Stega J; QRI LLC, 605 Majors Path, South Hampton, NY, 11938, USA., Noel MS; Division of Hematology/Oncology, James P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 704, Rochester, NY, 14642, USA., Vandell AG; Tyme Technologies, Inc., 17 State St. 7th floor, New York, NY, 10004, USA. Alexander.Vandell@tymeinc.com., Stega D; QRI LLC, 605 Majors Path, South Hampton, NY, 11938, USA., Del Priore G; Tyme Technologies, Inc., 17 State St. 7th floor, New York, NY, 10004, USA.; Morehouse School of Medicine, 720 Westview Drive, Atlanta, GA, 30310, USA., Hoffman S; Tyme Technologies, Inc., 17 State St. 7th floor, New York, NY, 10004, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2020 Apr; Vol. 38 (2), pp. 392-401. Date of Electronic Publication: 2019 Mar 30.
Autor:
Moore KN; Stephenson Cancer Center, University of Oklahoma, 800 NE 10th Street, Suite 5050, Oklahoma City, OK, 73104, USA.; The Sarah Cannon Research Institute/Tennessee Oncology, 250 25th Avenue North, Suite 110, Nashville, TN, 37203, USA., Bendell JC; The Sarah Cannon Research Institute/Tennessee Oncology, 250 25th Avenue North, Suite 110, Nashville, TN, 37203, USA., LoRusso PM; Division of Hematology and Oncology, Wayne State University, 4100 John R/4-HWCRC, Detroit, MI, 48201, USA., Olszanski AJ; Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA, 19111, USA., Zwick-Wallasch E; U3 Pharma GmbH, 82152, Martinsried, Germany., Jansen M; Daiichi Sankyo Development Ltd., Gerrards Cross, SL9 0BG, UK., Vandell AG; Daiichi Sankyo Inc., 211 Mt Airy Rd, Basking Ridge, NJ, 07290, USA. avandell@dsi.com., Senaldi G; Daiichi Sankyo Inc., 211 Mt Airy Rd, Basking Ridge, NJ, 07290, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2019 Feb; Vol. 37 (1), pp. 147-158. Date of Electronic Publication: 2018 Jul 28.
Autor:
Dennie J; Daiichi Sankyo Pharma Development, Basking Ridge, NJ, USA., Vandell AG; Daiichi Sankyo Pharma Development, Basking Ridge, NJ, USA., Inoue S; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Gajee R; Daiichi Sankyo Pharma Development, Basking Ridge, NJ, USA., Pav J; Daiichi Sankyo Pharma Development, Basking Ridge, NJ, USA., Zhang G; Daiichi Sankyo Pharma Development, Basking Ridge, NJ, USA., Zamora C; Worldwide Clinical Trials, San Antonio, TX, USA., Masuda N; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Uchiyama M; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Yamada M; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Senaldi G; Daiichi Sankyo Pharma Development, Basking Ridge, NJ, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2018 Dec; Vol. 58 (12), pp. 1557-1565. Date of Electronic Publication: 2018 May 10.
Autor:
Vandell AG; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, USA avandell@dsi.com., Inoue S; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Dennie J; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, USA., Nagasawa Y; Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan., Gajee R; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, USA., Pav J; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, USA., Zhang G; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, USA., Zamora C; Worldwide Clinical Trials, San Antonio, Texas, USA., Masuda N; Daiichi Sankyo Co., Ltd., Tokyo, Japan., Senaldi G; Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2018 Apr 26; Vol. 62 (5). Date of Electronic Publication: 2018 Apr 26 (Print Publication: 2018).
Autor:
Vandell AG; Translational Medicine & Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, NJ, USA., Lee J; Translational Medicine & Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, NJ, USA., Shi M; Translational Medicine & Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, NJ, USA., Rubets I; Pharsight Consulting Services, Montreal, Quebec, Canada., Brown KS; Translational Medicine & Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, NJ, USA., Walker JR; Translational Medicine & Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, NJ, USA.
Publikováno v:
The pharmacogenomics journal [Pharmacogenomics J] 2018 Jan; Vol. 18 (1), pp. 153-159. Date of Electronic Publication: 2016 Nov 29.
Autor:
Vandell AG; Translational Medicine Clinical Pharmacology, Daiichi Sankyo Pharma Development, Edison, New Jersey, USA., Walker J; Translational Medicine Clinical Pharmacology, Formerly of Daiichi Sankyo Pharma Development, Edison, New Jersey, USA., Brown KS; Translational Medicine Clinical Pharmacology, Formerly of Daiichi Sankyo Pharma Development, Edison, New Jersey, USA., Zhang G; Biostatistics, Daiichi Sankyo Pharma Development, Edison, NJ, USA., Lin M; Biostatistics, Daiichi Sankyo Pharma Development, Edison, NJ, USA., Grosso MA; Cardiovascular and Metabolism Therapeutic Area Development, Daiichi Sankyo Pharma Development, Edison, New Jersey, USA., Mercuri MF; Cardiovascular and Metabolism Therapeutic Area Development, Daiichi Sankyo Pharma Development, Edison, New Jersey, USA.
Publikováno v:
Heart (British Cardiac Society) [Heart] 2017 Nov; Vol. 103 (22), pp. 1800-1805. Date of Electronic Publication: 2017 Jul 08.
Autor:
Mega JL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: jmega@partners.org., Walker JR; Celgene Corporation, Summit, NJ, USA., Ruff CT; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Vandell AG; Daiichi Sankyo Pharma Development, Edison, NJ, USA., Nordio F; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Deenadayalu N; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Murphy SA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Lee J; Daiichi Sankyo Pharma Development, Edison, NJ, USA., Mercuri MF; Daiichi Sankyo Pharma Development, Edison, NJ, USA., Giugliano RP; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Antman EM; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Braunwald E; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: msabatine@partners.org.
Publikováno v:
Lancet (London, England) [Lancet] 2015 Jun 06; Vol. 385 (9984), pp. 2280-7. Date of Electronic Publication: 2015 Mar 11.